Nimixa 550mg Tablet

Description

 Nimixa 550mg Tablet

Nimixa 550mg Tablet (Rifaximin) is a non-aminoglycoside semi-synthetic, nonsystemic antibacterial derived from rifamycin SV. Rifaximin is a structural analog of rifampin. Chemically,  Nimixa 550mg Tablet is (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23- Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24, 26-octamethyl-1,15- dioxo-1,2-dihydro-2,7- (epoxypentadeca [1,11,13] trienoimino) benzofuro[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetate.  Nimixa 550mg Tablet molecular formula is C43H51N3O11. THERAPEUTIC INDICATIONS To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nimixa (Rifaximin) and other antibacterial drugs,  Nimixa 550mg Tablet (Rifaximin) when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Traveler’s Dia r r h e a N o t C a u s e d b y E s c h e r i c h i a c o l i Upon administration of Nimixa 550mg Tablet, discontinue rifaximin if diarrhea symptoms due to pathogens othe r than Es cherichia coli get wo r s e or persist more than 24-48 hours and alternative antibiotic therapy should be considered.

Contraindicated: – In patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the excipient of product. – During pregnancy and in women of childbearing potential not using contraception. – In the treatment of traveler’s diarrhea caused by invas ive enteri c pathogens suc h as Campylobacter, Salmonella and Shighella, whi ch typi call y produce dysentery like diarrhea characterized by fever .

Uses                                   

It is used to treat diarrhea caused by the common bacteria known as E. coli .

 Side effects

Nausea, vomiting,constipation, diarrhea, bloating

 When not use

Rifaximin is contraindicated: – In patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the excipient of product. – During pregnancy and in women of childbearing potential not using contraception. – In the treatment of traveler’s diarrhea caused by invas ive enteri c pathogens suc h as Campylobacter, Salmonella and Shighella, whi ch typi call y produce dysentery like diarrhea characterized by fever .